5.410USDMkt Cap: 7.01M USDP/E: —Last update: 2026-05-22
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product th…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap7.01M USD
Enterprise Value2.88M USD
Revenue (TTM)34.55K USD
Gross Profit-116 USD
Net Income (TTM)-24.48M USD
Revenue/Share0.4260 USD
Last Price5.410 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue83.42
P/S209.53
P/B0.24
EPS (TTM)-7.09
EPS (Forward)—
52W Range
5.30033% of range5.630
52W High5.630 USD
52W Low5.300 USD
Profitability
Gross Margin-1.87%
Oper. Margin-5805.98%
EBITDA Margin0.00%
Profit Margin-394725.06%
ROE383.93%
ROA-1865.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.92M USD
CapEx (TTM)—
FCF Margin63450.70%
FCF Yield312.90%
Net Debt-4.36M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.81
Current Ratio2.26
Quick Ratio1.86
Book Value/Sh23.10 USD
Cash/Share4.522 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateJan 16, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.30M
Float1.20M
Insiders0.96%
Institutions1.68%
Short Interest
Short Ratio0.0d
Short % Float17.35%
Short % Out.16.35%
Shares Short27.38K
Short (prev mo.)14.36K
Technical
SMA 501.572 (+244.2%)
SMA 2007.025 (-23.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)69.08K
Avg Vol (10d)3.78M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—